Market revenue in 2023 | USD 688.5 million |
Market revenue in 2030 | USD 1,590.1 million |
Growth rate | 12.7% (CAGR from 2023 to 2030) |
Largest segment | Tablets & softgels |
Fastest growing segment | Chewables & Gummies |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Chewables & Gummies, Capsules, Powders, Tablets & Softgels |
Key market players worldwide | DuPont de Nemours Inc, Symrise AG, Basf SE, Archer-Daniels Midland Co, Amway Malaysia Holdings, Abbott Laboratories, Bayer AG, Glanbia PLC, Pfizer Inc, BioGaia AB Class B, GSK PLC, Koninklijke DSM NV |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to probiotics dietary supplements market will help companies and investors design strategic landscapes.
Tablets & softgels was the largest segment with a revenue share of 40.22% in 2023. Horizon Databook has segmented the Italy probiotics dietary supplements market based on chewables & gummies, capsules, powders, tablets & softgels covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy probiotics dietary supplements market , including forecasts for subscribers. This country databook contains high-level insights into Italy probiotics dietary supplements market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account